long term growth potential Good revenue growth. New and experienced ceo Focusing on reducing dependency on Chinese market. Increasing sales in Europe.Got approval for patent on N-cell. Developing P-type cell. ROE up 14.05%last 4 qrts. Sales up 987.43% last 4 qrts. gross profit margin up 17.81% last 4 qrts. I wouldnt buy this for price to go up in next few days

Stock trading on good volume. Seems to have a solid customer base. Low historical p/e ratio. Hving troubles with its accounting practices and timeley filings.buisiness overall seems pretty solid otherwise. Stock seriously gapped down. I would buy this stock looking to see a price rebound over the next few days. 8/27/07 open 7.80 close 7.78

i wouldnt touch this one. Fianancials bad. stock price bad. just plain bad. dont like the biofuel play in general 8/27/07 up 8 cents. didnt take into account the popularity of biofuel in general. insider buying also, resulting in reduced debt. Still dont like it

this product too dependent on housing. it is a good product though. they have increased revenue consistently. ceo just quit. if i were to play this one it would be for a price bounce, but not likely 8/27/07 up47 cents on low volume. what the hey?